In particular, oxidative stress and inflammation modulate the AKT, ERK1/2, c-Jun, and NO-sGC-cGMP signaling pathways, which are crucial for cardiac function, leading to cardiomyocyte dysfunction, sarcomere damage and, consequently, cardiac hypertrophy [15]. The gene discussed is MAPK3; the disease is cardiac hypertrophy.